| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,418.40
|
|
Change (%)
|
-11.05 (-0.77%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,404.40
-
1,442.50
|
|
52-Week Range (RS)
|
1,165.55
-
1,672.20
|
|
Beta (1 Year)
|
0.52
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| USFDA inspects Cipla subsidiary's manufacturing unit in New York |
| Volumes jump at Biocon Ltd counter |
| Cipla Ltd soars 2.53%, up for fifth straight session |
| Cipla to convene board meeting |
| Cipla receives revision in ESG rating |
| Cipla climbs after brokerage backs stock with Rs 1,700 target price |
| Cipla appoints Shivam Puri as CEO-One India Business |
| Cipla arm names Shivam Puri CEO of One India Business, effective 1 July 2026 |
| Cipla receives VAI status for Goa plant from USFDA |
| Cipla allots 44,770 equity shares under ESOS |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013 |
Phone:91-22-24826000
Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
10-Jul-2026 |
1438.75 |
-1.41 |
| 1Month |
17-Jun-2026 |
1350.75 |
5.01 |
| 3Month |
17-Apr-2026 |
1238.30 |
14.54 |
| 6Month |
19-Jan-2026 |
1391.20 |
1.96 |
| 1Year |
17-Jul-2025 |
1482.45 |
-4.32 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Flexi Cap Fund |
2.80 |
2979.63 |
| Parag Parikh Flexi Cap Fund |
1.47 |
2103.09 |
| SBI Nifty 50 ETF |
0.75 |
1579.57 |
| HDFC Focused Fund |
3.73 |
1018.81 |
| ICICI Pru Value Fund |
1.35 |
813.21 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,933.10 |
-0.87 |
1,962.50 |
1,547.25 |
463,815.44 |
| Zydus Lifesciences Ltd |
1,142.75 |
-0.93 |
1,181.00 |
835.85 |
113,989.75 |
| Lupin Ltd |
2,442.10 |
-2.32 |
2,530.00 |
1,838.65 |
111,660.76 |
| Mankind Pharma Ltd |
2,491.45 |
-2.10 |
2,706.60 |
1,909.90 |
102,895.88 |
| Dr Reddys Laboratories Ltd |
1,210.85 |
-1.07 |
1,414.40 |
1,149.00 |
101,066.72 |
|
|
|
|